Come grow with us in Phoenix!
GCP is excited to announce a new partnership with Reddy GI! https://lnkd.in/g_z8r9Ve
Skip to main content
Come grow with us in Phoenix!
GCP is excited to announce a new partnership with Reddy GI! https://lnkd.in/g_z8r9Ve
To view or add a comment, sign in
Technical Leader | Radically Curious | Innovating Virtual Care with Computer Vision | Epic Certified | Clinical Workflow Nerd | Author | Happiest On, In or By the Water 🌊 🚣♀️ 🏄♀️
A Year of Journal Articles (Day 207/365) Zhang, Shan, Wei Cui, Shu Ding, Xiangyu Li, Xi-Wei Zhang, and Ying Wu. "A cluster-randomized controlled trial of a nurse-led artificial intelligence assisted prevention and management for delirium (AI-AntiDelirium) on delirium in intensive care unit: Study protocol." Plos one 19, no. 2 (2024): e0298793. Summary: Background: - Delirium is common in ICU patients and worsens their health outcomes. - Following the PADIS guidelines ("ABCDEF bundle") is important for preventing delirium, but adherence is low in practice. - AI-AntiDelirium, an AI-assisted tool, was developed to help nurses prevent and manage delirium. - A pilot study showed positive results for using AI-AntiDelirium in preventing delirium and improving patient outcomes. Methods: - A large-scale clinical trial will assess the impact of AI-AntiDelirium on ICU delirium. - Six ICUs in two hospitals will be randomly assigned to use AI-AntiDelirium or follow the PADIS guidelines. - Over 1450 patients aged 50+ will be included from each group. - The study will measure various outcomes, including: Incidence of ICU delirium Duration of delirium Length of ICU and hospital stay Mortality rates in ICU and hospital Patient cognitive function and daily living activities Nurse adherence to the ABCDEF bundle Discussion: - This trial aims to evaluate if AI-AntiDelirium effectively reduces delirium and improves outcomes while increasing adherence to guidelines. - If successful, it could significantly improve ICU delirium management in research and practice. I am interested to see the results of this one.
To view or add a comment, sign in
Accuracy of Epic's sepsis model faces scrutiny EHR vendor Epic's AI-powered sepsis model, which is used by hundreds of hospitals in the U.S., has faced scrutiny, CNBC reported April 3. Epic's model is used to predict sepsis, a potentially life-threatening bloodstream infection. But in 2023, a study published in JAMA found that the tool missed a higher share of true cases and was less timely than other sepsis tools. While EPIC has since fine-tuned and made changes to its sepsis prediction model in a bid to improve its accuracy and make its alerts more meaningful to clinicians, it will be interesting to see if the sepsis tool can improve sensitivity and specificity in the prediction of sepsis. I have always thought that EPIC cannot be everything to everyone and perform well in all that purports to deliver. #sepsis, #sepsisprediction, #sensitivity, #specificity, #falespositive, #falsenegatives https://lnkd.in/eJafiN9k
To view or add a comment, sign in
Public Health, Global Health and Infectious Diseases Research Physician | Young World Federation of Public Health Associations (Young WFPHA) Communications team | London, UK
New paper out today co-authored with Holly Tibble and George Opoku-Pare 🙌 How accurate is cause of death coding in asthma? What's the impact of automated vs human coding? Why is this important? Read our paper to find out! 📖
To view or add a comment, sign in
Learn more about our pediatric clinical trials, and how to get involved in a recent article on Edhat Online Magazine! https://lnkd.in/gNajJ7eM
To view or add a comment, sign in
Register now - space is limited! Optimal Care Grand Rounds Series: Evidence-Based Approach to Headache Management in Primary Care Wednesday, March 27, 2024 from 1–2:00 pm ET http://spr.ly/6043ktcTU This live webcast is designed to enhance primary care providers’ competency in managing headaches with a focus on evidence-based approaches. Participants will review migraine pathophysiology to better differentiate headache symptoms. Traditional and cutting-edge therapies will be examined to enable informed decision-making in clinical practice.
To view or add a comment, sign in
Several weeks ago, April Boyd, RN, BSN, OCN, Carevive's clinical product manager, unveiled the findings of a recent pilot study conducted in collaboration with Charleston Area Medical Center (CAMC). The study focused on evaluating the effectiveness of our clinical decision support pathways, known as STAIRS, and the results were presented at the 2023 Academy of Oncology Nurse & Patient Navigators (AONN) conference. What is Carevive STAIRS™ (Symptom Triage, Assessment, Intervention, and Response System)? Carevive STAIRS™ are the first-ever computerized cancer symptom management pathways that, when combined with Carevive PROmpt®, enable cancer care teams to proactively identify and resolve cancer symptoms before they become problematic, often leading to treatment holds, treatment discontinuations, or hospitalizations, all of which negatively impact treatment outcomes. A few proven benefits of Carevive STAIRS™: ✅ Directly supports nurses in educating patients with evidence-based recommendations for symptom care. ✅ Decrease the workload of APPs so they can focus on the patients who need their attention the most. ✅ Enhances communication with patients at home and provides visibility to even the mildest of symptoms so the care team can intervene sooner using evidence-based pathways to avoid symptoms becoming severe and requiring additional specialized care To learn more or to see a demo on Carevive STAIRS™, please reach out to our team: https://lnkd.in/e4g2mCiw April Boyd, Nadia Still DNP, RN #Prompt #rsm #patientexperience #patientreportedoutcomes #PROs #workingtogether #cancercareplatform #valuebasedcare #qualitycancercare
To view or add a comment, sign in
Our latest Web Education article provides a pragmatic overview on the pharmacological management of acute upper gastrointestinal bleeding (AUGIB), aimed at frontline clinicians who manage AUGIB with focus on pre-endoscopic and post-endoscopic pharmacological interventions 👉 https://bit.ly/4esmzav
To view or add a comment, sign in
The ICD-10-CM category I16 includes specific codes for hypertensive crises, allowing coders to distinguish between hypertensive urgency (I16.0) 🚨, hypertensive emergency (I16.1) 🆘, and unspecified hypertensive crisis (I16.9)❓. This differentiation facilitates accurate tracking of patients requiring immediate treatment for clinically significant hypertension. Note that accelerated or malignant hypertension should be coded using category I10-I15 instead. https://hubs.ly/Q02x7WKF0
To view or add a comment, sign in
We hope you enjoyed Aminoglycosides Versus Cephalosporins for Neonatal Sepsis: A Pro/Con Debate Considering Current and Future Proposed Susceptibility Testing Recommendations at #PediatRx33!
To view or add a comment, sign in
When in doubt, trust the index! My bacon was saved several times during my exam by remembering the ICD-10-CM index contains more nonessential modifying terms, clues, and cross references. That litte word "with" is huge when it comes to diabetes coding, too. #mbc #medicalcodingtraining #devrymbc #medicalcodingstudents #ICD10CM #cca #ccs #AHIMA
📌 Quick Reminder for Coders: Familiarize yourself with the essential links between diabetes and various conditions as outlined in the AHA Coding Clinic® for ICD-10-CM. Key conditions include amyotrophy, neuropathy, cataract, and more. Accurate coding requires understanding these automatic associations. For conditions with other causes, don’t link to diabetes without documentation. ttps://https://lnkd.in/g9FpUXcG
To view or add a comment, sign in
1,174 followers
Create your free account or sign in to continue your search
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.